
Interstitial Lung Disease Treatment
Interstitial lung disease treatment in India with HRCT, lung-function testing and subtype-specific antifibrotic, immunomodulatory, oxygen or rehabilitation care.
Related Conditions
Our services are FREE and by using our services your hospital bill does not increase!
About Interstitial Lung Disease Treatment
Interstitial lung disease (ILD) treatment in India depends on the exact ILD subtype, because inflammatory, fibrotic, autoimmune, exposure-related and drug-related lung diseases require different treatment strategies. The first priority is to establish the most likely diagnosis and determine whether the disease is stable, inflammatory, progressively fibrosing or already causing significant oxygen impairment.
Assessment is usually led by an ILD-focused pulmonologist and includes high-resolution CT (HRCT), pulmonary-function tests such as FVC and DLCO, oxygen saturation at rest and with exertion, and a detailed exposure and medicine history. Autoimmune testing is important when connective-tissue disease is possible. Selected patients may need bronchoscopy, multidisciplinary ILD review or lung biopsy when imaging and clinical findings do not provide a sufficiently confident diagnosis.
Treatment may include removal of a harmful exposure, corticosteroids or other immunomodulatory therapy for selected inflammatory ILDs, and antifibrotic medicines for appropriate progressive fibrotic disease. Pulmonary rehabilitation, vaccination, oxygen therapy and management of reflux, sleep-disordered breathing or other relevant conditions can support long-term care. Advanced disease may require lung-transplant assessment. Severe new breathlessness, rapidly falling oxygen levels, confusion or acute respiratory deterioration requires urgent local assessment rather than planned medical travel.
Cost in India depends on HRCT and pulmonary-function testing, autoimmune or other diagnostic investigations, medicines, oxygen requirements, rehabilitation and whether bronchoscopy, biopsy, hospital admission or transplant assessment is needed. Long-term antifibrotic therapy has a very different cost pathway from a diagnostic second opinion or a short course of treatment for inflammatory disease.
India has tertiary respiratory centres with pulmonologists, thoracic radiology, rheumatology collaboration, bronchoscopy, pulmonary rehabilitation and transplant referral pathways. Medical Help India is a connection platform that can connect medically stable international patients with an appropriate healthcare partner to review HRCT and lung-function trends, clarify the ILD subtype and provide an individual treatment and cost estimate.
What's Included
Why consider treatment in India?
Access to experienced specialists
Advanced treatment and diagnostic options
More affordable hospital care
Shorter waiting times for treatment
Help comparing hospitals, plans and costs
Support with appointments, travel and follow-up
Cost in India
USDFinal costs depend on the medical assessment, hospital, room category and clinical needs.
How it works
Share your details
Tell us about your health concerns, age and current location.
Receive a call
We call you to discuss your situation, needs and questions.
Receive a treatment plan
Get information about the most suitable treatment plan, hospital and estimated cost.
Choose your plan
Review the options and agree on your care and travel plan.
Get full support
Receive full support throughout every stage of your care journey.
Receive care in India
Receive your planned care with support throughout your stay.
Top Hospitals for Interstitial Lung Disease Treatment
View All Hospitals →
BLK-Max Super Speciality Hospital, New Delhi
New Delhi

Apollo Health City, Jubilee Hills, Hyderabad
Hyderabad

Apollo Hospitals, Bannerghatta Road, Bengaluru
Bengaluru

Kauvery Hospital, Alwarpet, Chennai
Chennai

Kokilaben Dhirubhai Ambani Hospital, Mumbai
Mumbai

SSB Heart & Multispeciality Hospital, New Delhi
New Delhi
Top Doctors for Interstitial Lung Disease Treatment
View All Doctors →
Dr. Sumant Mantri
Pulmonology & Respiratory Medicine · 19+ yrs

Dr. Srinivas Rajagopala
Pulmonology, Sleep Medicine & Lung Transplantation · 20+ yrs

Dr. SP Rai
Pulmonology & Interventional Pulmonology · 26+ yrs

Dr. Sandeep Nayar
Pulmonology · 32+ yrs
Dr. Partha Pratim Bose
Pulmonology, Sleep Medicine & Internal Medicine · 40+ yrs

Dr. Chandrakant Tarke
Pulmonology · 11+ yrs
Frequently Asked Questions
How much does Interstitial Lung Disease Treatment cost in India?
Cost depends on pulmonology review, HRCT and pulmonary-function testing, oxygen assessment, autoimmune or exposure-related investigations, medicines such as antifibrotic or immunomodulatory therapy, pulmonary rehabilitation and whether bronchoscopy, biopsy, hospital admission or transplant assessment is required. Long-term antifibrotic treatment has a different cost pathway from diagnostic review or short-term inflammatory treatment.
Which medical reports are useful to have ready for Interstitial Lung Disease Treatment?
Have ready: the latest HRCT chest images and report, pulmonary-function tests including FVC and DLCO when available, oxygen saturation or exercise-oxygen assessment, pulmonology notes and relevant autoimmune blood tests. Include previous bronchoscopy or lung-biopsy reports, exposure and smoking history, current oxygen use, all ILD medicines and earlier CT or lung-function results so the team can assess progression.
Are all interstitial lung diseases treated the same way?
No. Treatment differs substantially between inflammatory, fibrotic, autoimmune, exposure-related and other ILD subtypes.
Why is HRCT important in ILD assessment?
High-resolution CT can show characteristic patterns of inflammation or fibrosis and helps guide diagnosis, multidisciplinary review and treatment planning.
When are antifibrotic medicines used?
They are used for selected fibrotic ILDs when evidence and the patient’s diagnosis support them, rather than for every form of ILD.

Our services are FREE
We connect you with leading hospitals and specialists in India. You pay the hospital directly.
